If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS4 Cap. Regulatory News (SFOR)

Share Price Information for S4 Cap. (SFOR)

Share Price is delayed by 15 minutes
Get Live Data
36.00    -0.25 (-0.69%)
Bid:
34.55
Ask:
36.15
Spread: 1.60 (4.631%)
Market Cap: £239.71m
SFOR Live PriceLast checked at - London Stock Exchange

Intraday S4 Cap. Share Chart

Bonus Issue and Capital Reduction Update

12 Sep 2022 07:00

RNS Number : 0190Z
S4 Capital PLC
12 September 2022
 

12 September 2022

S4 Capital plc

("S4Capital" or "the Company")

 

Bonus Issue and Capital Reduction Update

Further to the publication on 14 May 2022 of the Notice of Annual General Meeting (the "Notice"), and the passing of all the required Resolutions at the Annual General Meeting of the Company on 16 June 2022, the Company announces that the final hearing in the Court process to convert its £205,717,000 merger reserve into a distributable reserve is expected to be held on 13 September 2022 (the "Court Hearing").

As described in the Notice, a bonus issue (the "Bonus Issue") of C ordinary shares, each having a nominal value to be determined as at the date of the Bonus Issue (each a "Capital Reduction Share"), shall occur on the evening of 12 September 2022 (being the day before the Court Hearing). Accordingly, the record time for the bonus issue shall be 6.00 p.m. on 12 September 2022 (the "Record Time"). The nominal value of each Capital Reduction Share shall be determined as described in the Notice. The Board does not intend to declare an interim dividend at this time, although it continues to review the advisability of declaring a modest dividend in future.

One Capital Reduction Share shall be issued for each ordinary share of 25p in issue as at the Record Time. In addition, and as described in the Notice, the Capital Reduction Shares will not be admitted to the standard listing segment of the Official List or to trading on any regulated market. No share certificates will be issued in respect of the Capital Reduction Shares. The Capital Reduction Shares will have extremely limited rights. In particular, the Capital Reduction Shares will carry no rights to vote, no rights to participate in the profits of the Company and no rights to participate in the Company's assets save on a winding-up. The Capital Reduction Shares will be transferable, but it is not expected that any market in them will develop and it is anticipated that the Court will confirm their cancellation at the Court Hearing on the day immediately after the date on which they have been issued.

The Company will announce the outcome of the Court Hearing on 13 September 2022.

Capitalised terms used in this announcement which are not otherwise defined have the same meaning as in the Notice, which is available at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website at https://www.s4capital.com/investors.

Enquiries:

S4 Capital plc Tel: +44 (0)20 3793 0003/+44 (0)20 3793 0007

Sir Martin Sorrell (Executive Chairman)

Powerscourt Tel: +44 (0)778 670 2526

(PR Adviser to S4 Capital plc)

 

Robin O'Kelly 

Jane Glover

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFEDARILLIF
Date   Source Headline
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20244:24 pmRNSDirector/PDMR Shareholding
26th Jan 20247:00 amRNSShare Buyback Programme
22nd Jan 20241:55 pmRNSReplacement: Fourth Quarter Trading Update
22nd Jan 20247:00 amRNSFourth Quarter Trading Update
16th Jan 20244:21 pmRNSTrading Statement to be released 22nd January
2nd Jan 202412:01 pmRNSTotal Voting Rights
20th Dec 202310:37 amRNSHolding(s) in Company
18th Dec 20233:36 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSIssue of Shares
9th Nov 20237:00 amRNSThird Quarter Trading Update
1st Nov 20237:00 amRNSTotal Voting Rights
27th Oct 20237:00 amRNSQ3 Trading Update to be released on 9th November
27th Oct 20237:00 amRNSIssue of Shares
11th Oct 20237:00 amRNSIssue of Shares
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20232:02 pmRNSHolding(s) in Company
18th Sep 202310:00 amRNSHolding(s) in Company
18th Sep 20237:00 amRNSInterim Results for 2023
4th Sep 20237:00 amRNSNotice of Interim Results
1st Sep 20239:00 amRNSIssue of Shares
1st Sep 20237:00 amRNSTotal Voting Rights
3rd Aug 20237:00 amRNSIssue of Shares
24th Jul 20237:00 amRNSTrading Update
14th Jul 202310:00 amRNSDirector/PDMR Shareholding
3rd Jul 20232:00 pmRNSTotal Voting Rights
28th Jun 20237:00 amRNSArtificial Intelligence Briefing
22nd Jun 20237:00 amRNSIssue of Shares
9th Jun 20234:17 pmRNSResult of AGM
9th Jun 20237:00 amRNSAGM Statement
2nd Jun 20237:00 amRNSIssue of Shares
16th May 20239:00 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSFirst Quarter Trading Update
9th May 20237:00 amRNSNotice of Q1 Results
28th Apr 20237:00 amRNSAnnual Financial Report and Notice of AGM
17th Apr 20237:00 amRNSUpdate regarding Executive Chair
29th Mar 20234:51 pmRNSUnaudited 2022 preliminary results
15th Mar 20234:22 pmRNSNotice of Results
3rd Mar 202311:00 amRNSHolding(s) in Company
6th Feb 20234:05 pmRNSUpdate regarding Executive Chair
1st Feb 202310:00 amRNSTotal Voting Rights
18th Jan 20237:00 amRNSFourth Quarter Trading update
4th Jan 20237:00 amRNSIssue of Shares
3rd Jan 202310:24 amRNSTotal Voting Rights
13th Dec 20227:00 amRNSIssue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.